arrow
S

Stephanie L. Stout

Eli Lilly
H指数:9
被引数:896

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor
2021-06-0314
PREAI
Defining Target Engagement Required for Efficacy In Vivo at the Retinoic Acid Receptor-Related Orphan Receptor C2 (RORγt)
2021-04-144
PRE
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraints
2020-01-0113
PREAI
Preparation and biological evaluation of conformationally constrained BACE1 inhibitors
2015-07-0116
OAAI
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
2012-12-29142
OAAI